Selected article for: "cc NC ND International license and disease control"
Author: Akshaya Srikanth Bhagavathula; Wafa Ali Aldhaleei; Jamal Rahmani; Mohammadjavad Ashrafi Mahabadi; Deepak Kumar Bandari
Title: Novel Coronavirus (COVID-19) Knowledge and Perceptions: A Survey of Healthcare Workers
  • Document date: 2020_3_13
    • ID: 6xu7q927_3
    Snippet: COVID-19 is spread by human-to-human transmission through droplet, feco-oral, and direct contact and has an incubation period of 2-14 days [6] . To date, no antiviral treatment or vaccine has been explicitly recommended for COVID-19. Therefore, applying preventive measures to control COVID-19 infection is the most critical intervention. Healthcare workers (HCWs) are the primary sector in contact with patients and are an important source of exposu.....
    Document: COVID-19 is spread by human-to-human transmission through droplet, feco-oral, and direct contact and has an incubation period of 2-14 days [6] . To date, no antiviral treatment or vaccine has been explicitly recommended for COVID-19. Therefore, applying preventive measures to control COVID-19 infection is the most critical intervention. Healthcare workers (HCWs) are the primary sector in contact with patients and are an important source of exposure to infected cases in healthcare settings; thus, HCWs are expected to be at high risk of infection. By the end of January, the WHO and Centers for Disease Control and Prevention (CDC) had published recommendations for the prevention and control of COVID-19 for HCWs [8, 9] . The WHO also initiated several online training sessions and materials on COVID-19 in various languages to strengthen preventive strategies, including raising awareness and training HCWs in preparedness activities [10] . In several instances, . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antiviral treatment and control prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral treatment and critical intervention: 1, 2
    • antiviral treatment and direct contact: 1, 2, 3, 4, 5
    • antiviral treatment and healthcare setting: 1
    • antiviral treatment and Healthcare worker: 1, 2, 3, 4
    • antiviral treatment and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral treatment and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral treatment and human human transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • antiviral treatment and human human transmission spread: 1
    • antiviral treatment and important source: 1, 2
    • antiviral treatment and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • cc NC ND International license and healthcare setting: 1
    • cc NC ND International license and Healthcare worker: 1
    • cc NC ND International license and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • cc NC ND International license and human human transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc NC ND International license and human human transmission spread: 1
    • cc NC ND International license and important source: 1
    • cc NC ND International license and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25